IRADIMED CORPORATION (IRMD)
- Previous Close
41.47 - Open
41.94 - Bid 41.72 x 100
- Ask 42.28 x 200
- Day's Range
41.60 - 42.11 - 52 Week Range
36.12 - 51.04 - Volume
15,821 - Avg. Volume
57,688 - Market Cap (intraday)
531.96M - Beta (5Y Monthly) 0.86
- PE Ratio (TTM)
31.11 - EPS (TTM)
1.35 - Earnings Date May 2, 2024
- Forward Dividend & Yield 0.15 (0.36%)
- Ex-Dividend Date Dec 21, 2023
- 1y Target Est
62.50
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
www.iradimed.comRecent News: IRMD
Performance Overview: IRMD
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IRMD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IRMD
Valuation Measures
Market Cap
525.18M
Enterprise Value
477.46M
Trailing P/E
30.72
Forward P/E
27.10
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.05
Price/Book (mrq)
7.35
Enterprise Value/Revenue
7.28
Enterprise Value/EBITDA
22.95
Financial Highlights
Profitability and Income Statement
Profit Margin
26.22%
Return on Assets (ttm)
14.10%
Return on Equity (ttm)
23.70%
Revenue (ttm)
65.56M
Net Income Avi to Common (ttm)
17.19M
Diluted EPS (ttm)
1.35
Balance Sheet and Cash Flow
Total Cash (mrq)
49.76M
Total Debt/Equity (mrq)
2.86%
Levered Free Cash Flow (ttm)
8.4M